Teizo Asano

1.4k total citations
82 papers, 858 citations indexed

About

Teizo Asano is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Teizo Asano has authored 82 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 38 papers in Immunology and 37 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Teizo Asano's work include Monoclonal and Polyclonal Antibodies Research (36 papers), Immunotherapy and Immune Responses (26 papers) and Glycosylation and Glycoproteins Research (25 papers). Teizo Asano is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (36 papers), Immunotherapy and Immune Responses (26 papers) and Glycosylation and Glycoproteins Research (25 papers). Teizo Asano collaborates with scholars based in Japan. Teizo Asano's co-authors include Mika K. Kaneko, Yukinari Kato, Junko Takei, Hiroyuki Suzuki, Masato Sano, Hideki Hosono, Takuro Nakamura, Tomohiro Tanaka, Ren Nanamiya and Miyuki Yanaka and has published in prestigious journals such as International Journal of Molecular Sciences, Pharmaceutics and International Journal of Molecular Medicine.

In The Last Decade

Teizo Asano

82 papers receiving 858 citations

Peers

Teizo Asano

ONCOL

IMMUN

RNMI

Shunsuke Itai Japan

Sheila Spada United States

Mieke Versluis Netherlands

Vidyalakshmi Chandramohan United States

Yannick Guilloux France

Casey W. Shuptrine United States

Michele Rhodes United States

Hugues J. M. Nicolay Italy

Mei‐Kuang Chen United States

Céline M. Laumont Canada

Shunsuke Itai Japan

Teizo Asano

723 ×1.2

ONCOL

308 ×0.7

IMMUN

359 ×1.2

241 ×0.8

RNMI

70 ×0.7

Citations per year, relative to Teizo Asano Teizo Asano (= 1×) peers Shunsuke Itai

Countries citing papers authored by Teizo Asano

Since Specialization

Citations

This map shows the geographic impact of Teizo Asano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teizo Asano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teizo Asano more than expected).

Fields of papers citing papers by Teizo Asano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teizo Asano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teizo Asano. The network helps show where Teizo Asano may publish in the future.

Co-authorship network of co-authors of Teizo Asano

This figure shows the co-authorship network connecting the top 25 collaborators of Teizo Asano. A scholar is included among the top collaborators of Teizo Asano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teizo Asano. Teizo Asano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Asano, Teizo, et al.. (2023). Determination of the Binding Epitope of an Anti-Mouse CCR9 Monoclonal Antibody (C9Mab-24) Using the 1× Alanine and 2× Alanine-Substitution Method. Antibodies. 12(1). 11–11. 1 indexed citations

Li, Guanjie, Hiroyuki Suzuki, Tomokazu Ohishi, et al.. (2023). Antitumor activities of a defucosylated anti‑EpCAM monoclonal antibody in colorectal carcinoma xenograft models. International Journal of Molecular Medicine. 51(2). 20 indexed citations

Asano, Teizo, Hiroyuki Suzuki, Tomohiro Tanaka, Mika K. Kaneko, & Yukinari Kato. (2022). Identification of the Binding Epitope of an Anti-mouse CCR4 Monoclonal Antibody, C ₄ Mab-1. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(4). 214–220. 2 indexed citations

Li, Guanjie, Hiroyuki Suzuki, Teizo Asano, et al.. (2022). Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications. Antibodies. 11(2). 41–41. 16 indexed citations

Tanaka, Tomohiro, Guanjie Li, Masaki Saito, et al.. (2022). Development of an Anti-human CCR2 Monoclonal Antibody (C ₂ Mab-9) by N-Terminal Peptide Immunization. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(4). 188–193. 5 indexed citations

Tanaka, Tomohiro, Hiroyuki Suzuki, Teizo Asano, et al.. (2022). Epitope Mapping Using the Cell-Based 2 × Alanine Substitution Method About the Anti-mouse CXCR6 Monoclonal Antibody, Cx ₆ Mab-1. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 42(1). 22–26. 3 indexed citations

Tanaka, Tomohiro, Guanjie Li, Teizo Asano, et al.. (2022). Epitope Mapping of the Anti-Human CCR2 Monoclonal Antibody C ₂ Mab-9. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(3). 150–156. 3 indexed citations

Asano, Teizo, Hiroyuki Suzuki, Tomohiro Tanaka, et al.. (2022). Establishment of a Sensitive Monoclonal Antibody Against Mouse CCR9 (C ₉ Mab-24) for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 42(1). 15–21. 4 indexed citations

Suzuki, Hiroyuki, Tomokazu Ohishi, Guanjie Li, et al.. (2022). Antitumor Activities in Mouse Xenograft Models of Canine Fibroblastic Tumor by Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(2). 67–73. 5 indexed citations

10.

Suzuki, Hiroyuki, et al.. (2022). Development of a Monoclonal Antibody PMab-292 Against Ferret Podoplanin. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(2). 101–109. 10 indexed citations

11.

Saito, Masaki, Guanjie Li, Teizo Asano, et al.. (2022). C ₃ Mab-2: An Anti-Mouse CCR3 Monoclonal Antibody for Immunocytochemistry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(1). 45–49. 6 indexed citations

12.

Asano, Teizo, Hiroyuki Suzuki, Mika K. Kaneko, & Yukinari Kato. (2022). Epitope Mapping of Rituximab Using HisMAP Method. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(1). 8–14. 4 indexed citations

13.

Asano, Teizo, Tomokazu Ohishi, Junko Takei, et al.. (2021). An Anti-HER2 Monoclonal Antibody H ₂ Mab-41 Exerts Antitumor Activities in Mouse Xenograft Model Using Dog HER2-Overexpressed Cells. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(4). 184–190. 12 indexed citations

14.

Nanamiya, Ren, Junko Takei, Teizo Asano, et al.. (2021). Development of Anti-Human CC Chemokine Receptor 9 Monoclonal Antibodies for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(3). 101–106. 37 indexed citations

15.

Asano, Teizo, Ren Nanamiya, Junko Takei, et al.. (2021). Development of Anti-Mouse CC Chemokine Receptor 3 Monoclonal Antibodies for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 40(3). 107–112. 37 indexed citations

16.

Kato, Yukinari, Tomokazu Ohishi, Masato Sano, et al.. (2020). H ₂ Mab-19 Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody Therapy Exerts Antitumor Activity in Pancreatic Cancer Xenograft Models. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 39(3). 61–65. 5 indexed citations

17.

Kato, Yukinari, Yuji Ito, Tomokazu Ohishi, et al.. (2020). Antibody–Drug Conjugates Using Mouse–Canine Chimeric Anti-Dog Podoplanin Antibody Exerts Antitumor Activity in a Mouse Xenograft Model. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 39(2). 37–44. 8 indexed citations

18.

Kaneko, Mika K., Tomokazu Ohishi, Takuro Nakamura, et al.. (2020). Development of Core-Fucose-Deficient Humanized and Chimeric Anti-Human Podoplanin Antibodies. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 39(5). 167–174. 20 indexed citations

19.

Yamada, Shinji, Mika K. Kaneko, Yusuke Sayama, et al.. (2020). Development of Novel Mouse Monoclonal Antibodies Against Human CD19. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 39(2). 45–50. 16 indexed citations

20.

Kato, Yukinari, Tomokazu Ohishi, Junko Takei, et al.. (2020). An Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H ₂ Mab-19 Exerts Antitumor Activity in Mouse Colon Cancer Xenografts. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 39(4). 123–128. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact